(R)-Monlunabant
Product Specifications
UNSPSC Description
(R)-Monlunabant ((R)-MRI-1891) is a CB1 receptor mediators for research of obesity and metabolic disease[1]
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/r-monlunabant.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(N/C(N1N=C(C2=CC=C(C=C2)Cl)[C@H](C3=CC=CC=C3)C1)=N/C(NC(C)=O)=N)(C4=CC=C(C=C4)C(F)(F)F)=O
Molecular Weight
591.00
References & Citations
[1]George Kunos, et al. Cannabinoid receptor mediating compounds. Patent. US20180273485.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153800A/R-Monlunabant-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153800A/
Clinical Information
No Development Reported
CAS Number
2765579-76-6
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
